Literature DB >> 3598072

Lack of prolactin involvement in corticosteroid secretion.

J N Hugues, E Modigliani, F Girard, J Sebaoun.   

Abstract

In mammals prolactin can modify adrenal steroidogenesis. Its trophic effect on adrenal cells where prolactin receptors have been identified suggest a direct impact upon corticosteroid biosynthesis. In man, this role of prolactin remains controversial. The purpose of our study was to investigate the effects of chronic hyperprolactinemia on basal and stimulated corticosteroid hormone secretion. Seven women with untreated chronic hyperprolactinemia (HPRL) were included in the study. In each of them, a beta 1-24 ACTH test was performed on a normal and low Na+ diet for 4 days. Basal and ACTH-stimulated cortisol, aldosterone, deoxycorticosterone and 17 hydroxyprogesterone secretion were not significantly different in HPRL and NPRL women. These results do not support evidence for any significant role of prolactin upon corticosteroid biosynthesis in man. They also suggest that prolactin is not the pituitary factor which modulates ACTH or low Na+ diet stimulated corticosteroid secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3598072     DOI: 10.1007/BF03347142

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Aldosterone secretion during high sodium cerebrospinal fluid perfusion of the brain ventricles.

Authors:  S F Abraham; J R Blair-West; J P Coghlan; D A Denton; D R Mouw; B A Scoggins
Journal:  Acta Endocrinol (Copenh)       Date:  1976-01

Review 2.  Perspectives in aldosterone and renin control.

Authors:  J P Coghlan; J R Blair-West; D A Denton; B A Scoggins; R D Wright
Journal:  Aust N Z J Med       Date:  1971-05

3.  Actions of prolactin on human renal function.

Authors:  D F Horrobin; I J Lloyd; A Lipton; P G Burstyn; N Durkin; K L Muiruri
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

4.  Control of aldosterone secretion by the pituitary gland.

Authors:  W P Palmore; P J Mulrow
Journal:  Science       Date:  1967-12-15       Impact factor: 47.728

5.  Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.

Authors:  C R Edwards; P A Miall; J P Hanker; M O Thorner; E A Al-Dujaili; G M Besser
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

6.  Failure of endogenous prolactin to alter renal salt and water excretion and adrenal function in man.

Authors:  G Baumann; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1976-09       Impact factor: 5.958

7.  In vivo and in vitro studies on the effect of metoclopramide on aldosterone secretion.

Authors:  C R Edwards; E A Al-Dujaili; M Boscaro; S Quyyumi; P A Miall; L H Rees
Journal:  Clin Endocrinol (Oxf)       Date:  1980-07       Impact factor: 3.478

8.  Effect of prolactin on plasma DHEA (s) levels.

Authors:  A Vermeulen; E Suy; R Rubens
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

9.  Development and preliminary application of a new assay for aldosterone stimulating factor.

Authors:  S Sen; F M Bumpus; S Oberfield; M I New
Journal:  Hypertension       Date:  1983 Mar-Apr       Impact factor: 10.190

10.  Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.

Authors:  R M Carey; S Sen; L M Dolan; C D Malchoff; F M Bumpus
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.